

AIM-listed pharmaceuticals company Vernalis has received a 1.5m dollar payment under its drug discovery collaboration with Genentech, a member of the ...


AIM-listed pharmaceutical company Vernalis has published positive results for a study of potential applications for Parkinson's disease and other cent...


Vernalis, a development stage pharmaceutical company, saw first half losses halve on the back of a sharp rise in revenues, driven by a significant inc...


The drug development firm Vernalis has reported a successful outcome in Phase I trials of its V81444 treatment that may be useful in the fight against...


Questor, in the Telegraph, gives some quite clear advice on Ryanair: sell. The shares have risen 78% since the first tip back in 2009 and the oil pr...


Shares in Vernalis, a UK pharmaceuticals company, were marked up after the company said it has placed shares at a premium to fund a drug development p...


Shares in Vernalis rose this morning after the pharmaceutical firm said tests on its new painkiller had so far proved successful. The firm said that ...


The miners are on the decline Tuesday, helped lower by the falling metals prices. Copper and gold futures have fallen as the escalating crisis in Japa...